Jain told CNBC-TV18, "Matrix Laboratories is consolidating, the midcap pharma healthcare stocks have not moved up in the last two years. It has support at Rs 238. The next target is at Rs 250 and then Rs 266 being the next target. So I would advise the investor to hold as well."
